Karim Belarbi, …, Marie-Christine Chartier-Harlin
Featured Research: The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions
Mari Takalo, …, Mikko Hiltunen and Christian Haass
Alzheimer's Disease: Challenges for the next decade
Molecular Neurodegeneration presents a new thematic series, collating reviews which present and evaluate the challenges for the next decade of research into Alzheimer's disease.
Edited by Guojun Bu, Alison Goate and Todd Golde, reviews will continue to publish throughout 2021. The collection can be read here.
News from Alzforum
16 January 2021
15 January 2021
14 January 2021
The leading open access journal in the field of neurosciences, Molecular Neurodegeneration encompasses all aspects of neurodegeneration research at the molecular and cellular levels.
- Guojun Bu, Mayo Clinic, USA
- Huaxi Xu, Sanford Burnham Prebys Medical Discovery Institute, USA
Molecular Neurodegeneration is the official journal of the BrightFocus Foundation.
Annual Journal Metrics
43 days to first decision for reviewed manuscripts only
20 days to first decision for all manuscripts
121 days from submission to acceptance
23 days from acceptance to publication
570 Altmetric mentions